![]() ![]() This approval proffers health care professionals a novel way to treat burn wounds. That procedure leaves a new wound where the healthy skin was removed. Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, elucidated that skin grafts are often the patient’s healthy skin taken from their body and moved to the burned area to help it heal. The use of Stratagraft can help avoid or reduce the amount of healthy skin required for grafting. Over time, the patient’s skin cells should grow to substitute the skin cells lost due to the burn. Designed for topical application, it can be sutured, stapled, or secured with adhesive. It comprises a living dermal matrix containing dermal fibroblasts and is overlaid with human epidermal cells. Stratagraft, which includes human keratinocytes and dermal fibroblasts in an engineered, bilayer construct, is designed to mimic natural human skin, both its inner dermis-like and outer epidermis-like layers. The company said regenerative skin tissue therapy could lessen or eliminate the requirement of autografting of healthy skin to treat burn wounds. ![]() Mallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. Mallinckrodt earns FDA nod for regenerative skin therapy for burns Umoja banks USD 210 Million to bring next-gen tumor tagging immunotherapies into the clinic.VectorY raises USD 38 Million to develop Alzheimer’s, ALS gene therapies.RayzeBio secures USD 108 Million to boost its radiopharmaceuticals approach to solid tumors.Mallinckrodt earns FDA nod for regenerative skin therapy for burns. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |